Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial

Robert K. Dyer, Martin A. Weinstock, Tobias S.D. Cohen, Amilcar E. Rizzo, Stephen F. Bingham, Martin A. Weinstock, Kimberly Marcolivio, Martin Wainstock, Stephen Binghem, John DiGiovanna, Russell Hall, Mark Naylor, J. Richard Taylor, Julia Vertrees, Clifton White, Russell Hell, Deborah Hannah, David Eilers, Tehming Liang, Nadia SaklaAnn Kreuger, Gary Cole, Edward Jeffes, Terri Labrador, J. Richard Taylor, Robert Kirsner, Jonette E. Kerri, Anna G. Falabella, Margarita Givens, Mark Neylor, Mary Beth Benson, Lisa Perry, James Kalivas, Catherine Yanni, Selma Targovnik, Janet Austin, Susan Collier, Joseph F. Collins, Stephen Bingam, Beverly Calvert, Philip Connor, Colleen Crigler, Dawn Davis, Pat Grubb, Judy Kelly, Gail Kirk, Karen Lawson, Linda Linzy, Lorrine Palmer, Maxine Rhoads, Mike Sather, Erica Copeland, Carol Fye, William Gagne, Patricia Grimes De Naranjo, Chad Messick, Julia Vertreas, Michael Piepkorn, Clifton Whita, Robert Lew, Irwin Braverman, Bernard Cole, Richard Kalish, David McLean, Bruce Thiers

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds